↓ Skip to main content

A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response

Overview of attention for article published in International Journal of Hematologic Oncology, December 2019
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response
Published in
International Journal of Hematologic Oncology, December 2019
DOI 10.2217/ijh-2019-0010
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 4 22%
Student > Master 3 17%
Student > Bachelor 2 11%
Other 1 6%
Student > Ph. D. Student 1 6%
Other 1 6%
Unknown 6 33%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 6 33%
Environmental Science 1 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Agricultural and Biological Sciences 1 6%
Other 2 11%
Unknown 6 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2020.
All research outputs
#20,667,544
of 25,387,668 outputs
Outputs from International Journal of Hematologic Oncology
#58
of 91 outputs
Outputs of similar age
#357,323
of 474,531 outputs
Outputs of similar age from International Journal of Hematologic Oncology
#1
of 1 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 91 research outputs from this source. They receive a mean Attention Score of 2.8. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 474,531 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them